Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02109588
Other study ID # Prevention childhood obesity
Secondary ID
Status Recruiting
Phase N/A
First received March 31, 2014
Last updated November 13, 2014
Start date March 2014
Est. completion date April 2018

Study information

Verified date October 2013
Source Technical University of Madrid
Contact Maria Perales Santaella, PhD student
Phone 913364081
Email m.perales.santaella@gmail.com
Is FDA regulated No
Health authority Spain: Comité Ético de Investigación Clínica
Study type Interventional

Clinical Trial Summary

The main aim of this study was to examine the effect of a supervised physical exercise program on the prevention of childhood obesity and its impact on the motor development of the offspring.


Description:

The environment where the fetus growths up is essential for the risk of developing some diseases in later life, such as obesity. Exercise has showed being useful in the prevention on excessive maternal weight gain which is linked to fetus weight.


Recruitment information / eligibility

Status Recruiting
Enrollment 1100
Est. completion date April 2018
Est. primary completion date August 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Being healthy and able to exercise following American College of Obstetricians and Gynecologists (ACOG) guidelines

- Being able to communicate in spanish

- Giving birth at Hospital Universitario de Torrejón, hospital Universitario de Puerta de Hierro and Hospital Universitario Severo Ochoa (Madrid).

Exclusion Criteria:

- Multiparity

- Obstetrician complications

- Being interested in the study after 16 weeks

- Not being regular in physical exercise program

- Younger than 18 years old

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
A supervised physical exercise program
Supervised physical conditioning program of three 55—60 minute sessions per week during whole pregnancy (from week 9 to 38). Each session consists of 25-30 minutes of cardiovascular exercise,10 minutes of specific exercises (strength and balance exercises), and 10 minutes of pelvic floor muscles training Aerobic activity was prescribed at light to moderate intensity, aiming for 55-60% of heart rate reserve. All subjects wore a heart rate (HR) monitor (Polar FT7) during the training sessions to ensure that exercise intensity was light to moderate

Locations

Country Name City State
Spain Universidad Politécnica de Madrid Madrid

Sponsors (1)

Lead Sponsor Collaborator
Technical University of Madrid

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Body mass index of the offsprings Body mass index was measured several times from 0 to 24 months 0-24 postpartum months No
Primary Fetus body composition Fetus body composition (percentage of fat) was measured several times from 0 to 24 months 0-24 postpartum months No
Primary Change from baseline in Maternal gestational weight gain Maternal weight gain during pregnancy 40-42 weeks of gestation No
Primary Changes in Baby motor development Baby motor development was measured after delivery 0-24 postpartum months No
Primary Recovery time to pre-gestational weight The time needed to recovery the pre-gestational weight was assessed. 6-12 postpartum months No
Primary Glycemia level of the offsprings Glycemia level of the offsprings was measured until 24 months 0-24 postpartum months No
Primary Postpartum depression The level of maternal depression was measured after delivery 0-12 postpartum months No
Primary Change from baseline in Body image satisfaction Body image satisfaction was measured during and after pregnancy up to 36 weeks No
Primary Changes from baseline in maternal quality of life Maternal quality of life was measured during and after pregnancy up to 36 weeks No
Primary Placenta measurements Placenta measurements were collected at labor At delivery No
Secondary Maternal outcomes Type of labor, stage of labor and some other maternal variables were measured at delivery At delivery Yes
Secondary Control of physical activity Control the level of physical activity during and after pregnancy up to 10 weeks No
Secondary Changes from delivery in Health of the offspring Health of the baby included the measurement of other variables such as blood pressure and cholesterol of the offsprings until 24 months 0-24 postpartum months No
Secondary Fetus outcomes Fetus outcomes were measured at delivery: Apgar score, PH umbilical cord, size and height of the baby, head circumference At delivery Yes
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Terminated NCT02546193 - Outpatient Foley Catheter Compared to Usual Inpatient Care for Labor Induction N/A